Over the last 10 years, West Pharmaceutical Services stock has attracted buying interest at this level 7 times and has subsequently produced an average ...

This pharma stock projected to post stout earnings growth is forming a bullish chart pattern despite the stock market carnage ...

Stay up-to-date with the Sun Pharma Stock Liveblog, your comprehensive source for real-time updates and detailed analysis on ...

The government has imposed a Minimum Import Price fixed at ₹2,216/kg for Penicillin G and is expected to provide a ...

SpyGlass Pharma Inc. (SGP) announced the pricing of its initial public offering of 9,375,000 shares at $16.00 per share, according to a company statement. The biopharmaceutical company expects to ...

Stay up-to-date with the Sun Pharma Stock Liveblog, your trusted source for real-time updates and thorough analysis of a ...

Why BridgeBio Pharma (BBIO) is on investors’ radar BridgeBio Pharma (BBIO) has drawn fresh attention after recent share price moves, with the stock showing mixed short term performance and stronger ...

At current levels, the stock is trading about 6.8 percent below its 52-week high and nearly 19.79 percent above its 52-week low.

The stock's 14-day relative strength index (RSI) is 30.63. For the uninitiated, a level above 70 is considered overbought or ...

Cipla faces a target price cut and 'Reduce' rating from Nuvama after Q3 profit miss; learn if this pharma stock is worth your attention now.

Sudarshan Pharma's stock price surged to ₹23.10, hitting a 10% upper circuit despite market weakness. The company reported ...

Baron Funds, an investment management company, released its fourth-quarter investor letter for the “Baron Health Care Fund”. A copy of the letter can be downloaded here. The fund rose 13.10% ...